GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $256,000 | 0.0% | 6 | 0.0% | 0.23% | +14.1% |
| Q1 2022 | $256,000 | -5.9% | 6 | -99.9% | 0.20% | +5.1% |
| Q4 2021 | $272,000 | -22.5% | 6,163 | -33.0% | 0.20% | -37.7% |
| Q3 2021 | $351,000 | -4.1% | 9,198 | 0.0% | 0.31% | +13.0% |
| Q2 2021 | $366,000 | -19.4% | 9,198 | -27.7% | 0.28% | -22.8% |
| Q1 2021 | $454,000 | -3.0% | 12,727 | 0.0% | 0.36% | -0.8% |
| Q4 2020 | $468,000 | +26.8% | 12,727 | +29.8% | 0.36% | +46.0% |
| Q3 2020 | $369,000 | -12.8% | 9,806 | -5.4% | 0.25% | -8.1% |
| Q2 2020 | $423,000 | +5.0% | 10,361 | -2.5% | 0.27% | -7.2% |
| Q1 2020 | $403,000 | -21.4% | 10,626 | -2.7% | 0.29% | +5.1% |
| Q4 2019 | $513,000 | +15.3% | 10,920 | +4.6% | 0.28% | -8.3% |
| Q3 2019 | $445,000 | -21.5% | 10,435 | -26.4% | 0.30% | -26.5% |
| Q2 2019 | $567,000 | -4.2% | 14,179 | 0.0% | 0.41% | -0.5% |
| Q1 2019 | $592,000 | +8.4% | 14,179 | -0.9% | 0.41% | -26.0% |
| Q4 2018 | $546,000 | -4.9% | 14,304 | 0.0% | 0.56% | +3.0% |
| Q3 2018 | $574,000 | – | 14,304 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |